Gp39 treatment decreases TRAF4 expression, suggesting that CD40-dependent growth inhibition is associated with altered levels of TRAF4, which acts as an inhibitor of apoptosis in MM (85). The gene discussed is TRAF4; the disease is Miyoshi myopathy.